Results of 20 years of research on the treatment of diabetic retinopathy.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 7845951.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Diabetic retinopathy is the leading cause of blindness in young adults, ages 20-55. Without treatment 50% of those with proliferative diabetic retinopathy will be blind within 5 years. Over the last 2 decades the National Eye Institute has supported four different multicenter randomized clinical trials for diabetic retinopathy. Implementation of the results from these clinical trials can markedly reduce the risk of blindness.
Medical subject headings
- Diabetic Retinopathy
- Imidazolidines